Genomics Reporting Implementation Guide
3.0.0 - STU3 International flag

This page is part of the Genetic Reporting Implementation Guide (v3.0.0: STU3) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version in its permanent home (it will always be available at this URL). For a full list of available versions, see the Directory of published versions

Example Observation: TMB-therapuDrug

Generated Narrative: Observation TMB-therapuDrug

status: Final

category: Laboratory, Genetics

code: Therapeutic Implication

subject: Substance Junior Hamsburg (official) Male, DoB: 1987-09-01 ( Medical record number: 1234567 (use: temp, period: 2021-01-01 --> (ongoing)))

effective: 2023-02-01

performer: Practitioner Test Dolin

derivedFrom: Observation Mutations/Megabase [# Ratio] in Tumor

component

code: Therapeutic Implication

value: cancer sensitive to pembrolizumab

component

code: Associated phenotype

value: Non-small cell lung cancer

component

code: Medication assessed

value: Pembrolizumab

component

code: Conclusion Text

value: Non-small cell lung cancer with high TMB is sensitive to pembrolizumab